Top Story

Infants younger than 3 months with pertussis show greater mortality risk

March 6, 2015

MEMPHIS, Tenn. — Infants aged younger than 3 months exhibited the highest morbidity and mortality from Bordetella pertussis infections, according to data presented at the St. Jude/PIDS Pediatric Infectious Diseases Research Conference.

Pertussis represents the fifth-leading cause of vaccine-preventable death in children aged younger than 5 years, predominantly occurring in low- to middle-income countries. To assess the burden of B. pertussis among infants aged younger than 1 year and evaluate outcomes of infants who were positive with pertussis, researcher Herberth G. Maldonado, MD, of the Universidad San Carlos de Guatemala, and colleagues examined nasopharyngeal swabs from infants with pertussis-like symptoms (n = 68) from November 2013 to October 2014.

Smoking, atherosclerosis common among MSM with HIV Meeting News Coverage

Smoking, atherosclerosis common among MSM with HIV

March 6, 2015
SEATTLE — Smoking rates appeared high among men who have sex with men with HIV and were associated with subclinical coronary atherosclerosis, according to data…
In the Journals

Infectious, noninfectious etiologies should be considered in diagnosis of temporal lobe encephalitis

March 5, 2015
In making the differential diagnosis of temporal lobe encephalitis, it is important to consider potential infectious and noninfectious etiologies in addition to the…
In the Journals

HCWs with influenza may not present with fever

March 5, 2015
Almost half of health care workers with influenza had no fever before their diagnosis, and they may put patients and co-workers at risk for influenza as a result…

EMA approves immunization schedule for pediatric 6-in-1 vaccine

March 5, 2015
The European Medicines Agency has approved a “2+1” immunization schedule for Hexyon, a pediatric vaccine that protects against multiple viruses, including…
More News Headlines »
CME
HCV Consults: Volume 1, Number 3

HCV Consults: Volume 1, Number 3

This activity is supported by educational grants from AbbVie and Genentech, Inc.

More »
Meeting News Coverage Video
thumbnail for video 4083453350001

Video: Action needed to reduce CVD risks in HIV patients

February 28, 2015
SEATTLE — Steven Grinspoon, MD, of the Massachusetts General Hospital and Harvard Medical School, gives an…
More »
CME
Regimen Selection in HIV

Regimen Selection in HIV: Considering New Options to Optimize Outcomes
Monograph

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than 2 decades into the antiretroviral therapy (ART) era, numerous options are available for HIV treatment. The…
More »
morganatic-roan
morganatic-roan